Author

Jeong Won Kim

Hallym UniversityORCID 0000-0002-6552-9875Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Divya NambiariD· 2 shared Freddy E. EscorciaiD· 2 shared Hima MakalaiD· 2 shared Joon‐Yong ChungiD· 2 shared Julia Sheehan‐KlenkiD· 2 shared Stanley FayniD· 2 shared Stephen M. HewittiD· 2 shared Woong Hee LeeiD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Divya NambiarORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathway

Joon‐Yong Chung, Hima Makala, Woong Hee Lee, Olivia W. Lee, Simran Khurana, Jeong Won Kim, Julia Sheehan‐Klenk, Divya Nambiar, Stanley Fayn, Ayla O. White, Eun Joo Chung, Nada Alani, Sabrina Ramelli, Stephen M. Hewitt, Travis H. Stracker, , Freddy E. Escorcia

This study shows that reducing GPC3 in liver cancer cells increases their sensitivity to radiation by extending G2/M arrest and activating the ATM/CHK2 pathway, with clinical evidence linking high GPC3 to worse outcomes in radiotherapy-treated HCC patients.

bioRxiv · May 14, 2026 · PreprintCancer Biology

Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for Radiotheranostics

Philip Homan, Joon‐Yong Chung, Woong Hee Lee, Divya Nambiar, Julia Sheehan‐Klenk, Hima Makala, Stanley Fayn, Orit Jacobson, Arthur Paden King, Kyungeun Kim, Jeong Won Kim, Sung Ryol Lee, Maggie Cam, Stephen M. Hewitt, Xin Wei Wang, , Freddy E. Escorcia

A multimodal pipeline defines and validates tumor-selective surface targets for radiotheranostic use in hepatocellular carcinoma.

bioRxiv · Nov 21, 2025 · PreprintCancer Biology